208 related articles for article (PubMed ID: 22008432)
1. Japanese-Western consensus meeting on biomarkers.
Maisel AS; Nakao K; Ponikowski P; Peacock WF; Yoshimura M; Suzuki T; Tsutamoto T; Filippatos GS; Saito Y; Seino Y; Minamino N; Hirata Y; Mukoyama M; Nishikimi T; Nagai R
Int Heart J; 2011; 52(5):253-65. PubMed ID: 22008432
[No Abstract] [Full Text] [Related]
2. [B-type natriuretic peptide for the diagnostic and prognostic assessment in cardiology. Its interest and perspectives of application].
Meune C; Fulla Y; Martins E; Bergmann JF; Devaux JY
Presse Med; 2003 Feb; 32(4):181-5. PubMed ID: 12610475
[TBL] [Abstract][Full Text] [Related]
3. [Do we need even more new biomarkers?].
Schnabel RB; Blankenberg S
Dtsch Med Wochenschr; 2013 Mar; 138(13):662-4. PubMed ID: 23512370
[No Abstract] [Full Text] [Related]
4. [Biomarkers in cardiology--state of the art 2007].
Mair J
Wien Med Wochenschr; 2007 Feb; 157(3-4):48-56. PubMed ID: 17340059
[TBL] [Abstract][Full Text] [Related]
5. [Value of N-terminal pro-brain natriuretic peptide in the early evaluation of cardiovasculardysfunction in critically ill children].
Chen Y; Yu Y
Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):149-52. PubMed ID: 24739730
[No Abstract] [Full Text] [Related]
6. Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care.
Thygesen K; Mair J; Mueller C; Huber K; Weber M; Plebani M; Hasin Y; Biasucci LM; Giannitsis E; Lindahl B; Koenig W; Tubaro M; Collinson P; Katus H; Galvani M; Venge P; Alpert JS; Hamm C; Jaffe AS;
Eur Heart J; 2012 Aug; 33(16):2001-6. PubMed ID: 21292681
[No Abstract] [Full Text] [Related]
7. Should natriuretic peptide testing be incorporated into emergency medicine practice?
Hohl CM
CJEM; 2006 Jul; 8(4):259-61. PubMed ID: 17324305
[No Abstract] [Full Text] [Related]
8. [Natriuretic peptide (BNP, NT-proBNP): differential use of diagnostic tests].
Steurer J
Praxis (Bern 1994); 2009 Jul; 98(15):795-6. PubMed ID: 19725192
[No Abstract] [Full Text] [Related]
9. Limitations of N-Terminal Pro-B-Type Natriuretic Peptide in the Diagnosis of Heart Disease among Cancer Patients Who Present with Cardiac or Pulmonary Symptoms.
Wieshammer S; Dreyhaupt J; Müller D; Momm F; Jakob A
Oncology; 2016; 90(3):143-50. PubMed ID: 26871423
[TBL] [Abstract][Full Text] [Related]
10. [B-type natriuretic peptide--current use in the diagnosis and management of heart failure].
Müller C; Kuster G; Büttner HJ; Buser P
Herz; 2003 Aug; 28(5):374-9. PubMed ID: 12928736
[TBL] [Abstract][Full Text] [Related]
11. Short-term mortality risk in emergency department acute heart failure.
Peacock WF; Nowak R; Christenson R; DiSomma S; Neath SX; Hartmann O; Mueller C; Ponikowski P; Möckel M; Hogan C; Wu AH; Richards M; Filippatos GS; Anand I; Ng LL; Daniels LB; Morgenthaler N; Anker SD; Maisel AS
Acad Emerg Med; 2011 Sep; 18(9):947-58. PubMed ID: 21906204
[TBL] [Abstract][Full Text] [Related]
12. [Comment on the study by H.G. Schneider et al.: "B-type natriuretic peptide testing, clinical outcomes, and health services use in emergency department patients with dyspnea"].
Krause M
Praxis (Bern 1994); 2009 Jul; 98(15):833-4. PubMed ID: 19642066
[No Abstract] [Full Text] [Related]
13. Biomarkers in clinical practice.
Alpert JS
Am J Med; 2011 Aug; 124(8):677-8. PubMed ID: 21683327
[No Abstract] [Full Text] [Related]
14. Natriuretic peptides in the diagnosis and management of heart failure.
Felker GM; Petersen JW; Mark DB
CMAJ; 2006 Sep; 175(6):611-7. PubMed ID: 16966666
[TBL] [Abstract][Full Text] [Related]
15. [The relevance of biomarkers in acute heart failure].
Hellenkamp K; von Haehling S
Internist (Berl); 2019 Jun; 60(6):587-596. PubMed ID: 31089771
[TBL] [Abstract][Full Text] [Related]
16. [Comment on the study by H.G. Schneider et al..: "B-type natriuretic peptide testing, clinical outcomes, and health services use in emergency department patients with dyspnea"].
Müller Ch
Praxis (Bern 1994); 2009 Jul; 98(15):835-6. PubMed ID: 19642067
[No Abstract] [Full Text] [Related]
17. The impact of B-type natriuretic peptide levels on the diagnoses and management of congestive heart failure.
Tabbibizar R; Maisel A
Curr Opin Cardiol; 2002 Jul; 17(4):340-5. PubMed ID: 12151866
[TBL] [Abstract][Full Text] [Related]
18. [Safe diagnosis in acute phase with T-proBNP. Heart failure and acute coronary syndrome can be identified very early].
Javadzadeh J; Collén AC; Manhem K; Swedberg K
Lakartidningen; 2008 Feb 27-Mar 4; 105(9):616-9. PubMed ID: 18376704
[No Abstract] [Full Text] [Related]
19. BNP and congestive heart failure.
Cowie MR; Mendez GF
Prog Cardiovasc Dis; 2002; 44(4):293-321. PubMed ID: 12007084
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of natriuretic peptides for acute heart failure: a review.
Zhou SL; Zhang J; Song TT; Li X; Wang HX
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2415-2420. PubMed ID: 29762843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
